期刊文献+

芳维A酸乙酯对Hut-78细胞增殖及凋亡的影响

Effects of Arotinoid Ethylester on Proliferation and Apoptosis of Hut-78 Cells
下载PDF
导出
摘要 目的观察并评价芳维A酸乙酯对皮肤T细胞淋巴瘤细胞(Hut-78)增殖及凋亡的影响。方法用不同浓度的维甲酸分别处理Hut-78细胞,用四甲基偶氮唑盐比色法(methyl thiazolyl tetrazolium,MTT)检测细胞增殖的抑制率、流式细胞仪检测细胞凋亡情况。结果经浓度为10-8 mol/L、10-7 mol/L、10-6 mol/L、10-5 mol/L的维甲酸分别作用于Hut-78细胞48 h,对细胞增殖的抑制率分别为(10.83±1.55)%、(17.71±3.60)%、(25.89±1.08)%、(30.92±1.86)%。用10-7 mol/L的维甲酸分别作用于Hut-78细胞12、24、36、48 h,其抑制率分别为(4.87±1.87)%、(10.87±0.77)%、(15.61±1.66)%、(19.57±1.80)%、(27.98±1.86)%。经浓度为10-7、10-5 mol/L的维甲酸作用48 h,Hut-78细胞的凋亡率分别为(11.56±1.51)%、(20.48±2.34)%。结论芳维A酸乙酯能够明显抑制Hut-78的增殖并能诱导细胞凋亡。 Objective To observe and evaluate the effects of arotinoid ethylester on proliferation and apoptosis of T lymphoma cells(Hut-78 cells).Methods Hut-78 cells were treated with different concentrations of arotinoid ethylester.Hut-78 cell proliferation and apoptosis was assessed by methyl thiazolyl tetrazolium(MTT) assay and Annexin V/PI doubled-labeled flow cytometry respectively.Results The inhibitory rate of Hut-78 cells was(10.83±1.55)%,(17.71±3.60)%,(25.89±1.08)%,(30.92±1.86)% respectively after the treatment with arotinoid ethylester at the concentration of 10-8,10-7,10-6,10-5 mol/L for 48 hours.The inhibitory rate of Hut-78 cells was(4.87±1.87)%,(10.87±0.77)%,(15.61±1.66)%,(19.57±1.80)%,(27.98±1.86)% respectively after the treatment with 10-7 mol/L arotinoid ethylester for 12,24,36 and 48 hours.The apoptotic rate of Hut-78 cells was(11.56±1.51)% and(20.48±2.34)% respectively after the treatment with arotinoid ethylester at the concentration of 10-7 and 10-5mol/L for 48 hour.Conclusion Arotinoid ethylester can significantly inhibit the proliferation and induce the apoptosis of Hut-78 cells.
出处 《华南国防医学杂志》 CAS 2011年第6期455-457,共3页 Military Medical Journal of South China
基金 国家自然科学基金项目(30771933)
关键词 芳维A酸乙酯 皮肤T淋巴细胞瘤 细胞增殖 细胞凋亡 Arotinoid ethylester Cutaneous T-cell lymphoma Cell proliferation Cell apoptosis
  • 相关文献

参考文献11

  • 1Sdnchez-Martinez R, Castillo AI, Steinmeyer A, et al. The reti- noid X receptor ligand restores defective signalling by the vitamin D receptor[J]. EMBO Rep,2006, 7(10) : 1030-1034.
  • 2Cheng C, Miehaels J, Scheinfeld N, et al. Alitretinoin: a com- prehensive review[J]. Expert Opin Investig Drugs,2008, 17(3): 437-443.
  • 3Mukherjee S, Date A, Patravale V, et al. Retinoids in the treat- ment of skin aging: an overview of clinical efficacy and safety[J]. Clin Interv Aging,2006, 1(4) : 327-348.
  • 4Kempf W, Kettelhack N, Duvic M, et al. Topical and systemic retinoid therapy for cutaneous T-cell lymphoma[J]. Hematol On- col Clin North Am,2003, 17(6) : 1405-1419.
  • 5Zhang C, Duvic M. Treatment of cutaneous T-cell lymphoma with retinoids[J]. Dermatol Ther,2006, 19(5): 264-271.
  • 6Guillemin MC, Raffoux E, Vitoux D, et al. In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia[J]. Exp Med,2002, 196(10) : 1373-1380.
  • 7Witcher M, Ross DT, Rousseau C, et al. Synergy between all- trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells[J]. Blood,2003,102(5) : 237-245.
  • 8Fau MM,Ratz AM,Sullivan KA, et al. Synthesis of novel retin- old X receptor selective retinoids[J]. Org Chem, 200l, 66(17): 5772-5782.
  • 9Witcher M, Shiu HY, Guo Q, et al. Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a va- riety of retinoic acid-resistant acute promyelocytie leukemia cells [J]. Blood,2004, 104(3): 3335-3342.
  • 10Klaus M, Debatin PF. Death receptors in chemotherapy and canc- er[J]. Oncogene,2004, 23(5) : 2950- 2966.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部